Page 1 of Clinical Trials for Drug Salmeterol MDI, 22 Total Matches

Show/Hide Clinical Trials Which are Not Seeking New Volunteers

1
Completed
A Six-week Study Comparing the Efficacy and Safety of Tiotropium Plus Formoterol to Salmeterol Plus Fluticasone in Chronic Obstructive Pulmonary Disease (COPD)
Last Updated: May 14, 2012
Condition(s): Pulmonary Disease, Chronic Obstructive
2
Completed
Efficacy and Safety of Tiotropium and Salmeterol in Moderate Persistent Asthma Patients Homozygous for B16-Arg/Arg
Last Updated: May 18, 2012
Condition(s): Asthma
3
Completed
A Pivotal Study of the Safety and Effectiveness of Arformoterol in Subjects With Chronic Obstructive Pulmonary Disease (COPD)
Last Updated: February 21, 2012
Condition(s): COPD
4
Completed
Determine the Safety and Efficacy of (R,R)-Formoterol in the Treatment of Subjects With COPD
Last Updated: February 21, 2012
Condition(s): Chronic Obstructive Pulmonary Disease; Chronic Bronchitis; Emphysema
5
Completed
A Comparison of the Effects of Tiotropium Inhalation qd and Salmeterol Inhalation Bid on Arterial Blood Gases.
Last Updated: May 11, 2012
Condition(s): Pulmonary Disease, Chronic Obstructive
6
Completed
To Evaluate the Long-term Safety of (R,R)-Formoterol in Subjects With COPD
Last Updated: February 21, 2012
Condition(s): Chronic Obstructive Pulmonary Disease; Chronic Bronchitis; Emphysema
7
Active, not recruiting
Evaluation of Tiotropium 2.5 and 5 Mcg Once Daily Delivered Via the Respimat® Inhaler Compared to Placebo and Salmeterol HydroFluoroAlkane (HFA) Metered Dose Inhaler (MDI) (50 Mcg Twice Daily) in Patient With Moderate Persistent Asthma I
Last Updated: May 11, 2012
Condition(s): Asthma
8
Active, not recruiting
Evaluation of Tiotropium 2.5 and 5 Mcg Once Daily Delivered Via the Respimat® Inhaler Compared to Placebo and Salmeterol HydroFluoroAlkane (HFA) Metered Dose Inhaler (MDI) (50 Mcg Twice Daily) in Patient With Moderate Persistent Asthma II
Last Updated: May 11, 2012
Condition(s): Asthma
9
Completed
Advair HFA For Chronic Obstructive Pulmonary Disease(COPD)
Last Updated: July 7, 2011
Condition(s): Pulmonary Disease, Chronic Obstructive; Chronic Obstructive Pulmonary Disease (COPD)
10
Completed
Study of Inhaled Glucocorticosteroids/Long-Acting Bronchodilator Drugs in Subjects With Asthma That Have Been Taking Inhaled Glucocorticosteroids (Study P04705AM1)
Last Updated: December 17, 2010
Condition(s): Asthma
11
Completed
Clinical Assessment Of GW815SF HFA MDI In Pediatric Patients With Bronchial Asthma
Last Updated: June 3, 2010
Condition(s): Bronchial Asthma
12
Completed
Tiotropium Once Daily 18 Mcg Versus Salmeterol Twice Daily 50 Mcg on Time to First Exacerbation in COPD Patients.
Last Updated: May 18, 2012
Condition(s): Pulmonary Disease, Chronic Obstructive
13
Completed
Clinical Assessment Of GW815SF Salmeterol/Fluticasone Propionate(HFA MDI) In Pediatric Patients With Bronchial Asthma -A Long Term (24-Week) Study-
Last Updated: June 18, 2009
Condition(s): Bronchial Asthma
14
Completed
Study of Mometasone Furoate/Formoterol Combination and Fluticasone/Salmeterol in Persistent Asthmatics Previously Treated With Inhaled Glucocorticosteroids (Study P04139AM1)(COMPLETED)
Last Updated: October 26, 2010
Condition(s): Asthma
15
Completed
Efficacy and Safety Comparison of Steroid or Placebo in Combination With Salmeterol and Tiotropium in COPD
Last Updated: May 28, 2009
Condition(s): Pulmonary Disease, Chronic Obstructive
16
Completed
Evaluation Of Patient Satisfaction Of Metered Dose Inhaler (MDI) With Counter In Asthmatics And Chronic Obstructive Pulmonary Disease Patients (COPD).
Last Updated: March 17, 2011
Condition(s): Asthma; Chronic Obstructive Airway Disease
17
Completed
Real-world Effectiveness of Combination Therapy in Asthma
Last Updated: June 9, 2010
Condition(s): Asthma
18
Completed
Effect of Salmeterol on Fluid Clearance From Alveolar-Capillary Membrane in COPD Patients
Last Updated: January 5, 2011
Condition(s): Salmeterol Effect Against an Acute Alveolar Fluid Clearance Challenge Secondary to Lung Fluid Overload in COPD Patients; Chronic Obstructive Pulmonary Disease; Bronchodilator Agents; Salmeterol
19
Recruiting
Onset of Action of Advair Hydrofluoroalkane (HFA) 115/21 in Comparison to Symbicort Pressurised Metered-Dose Inhalers (pMDI) 160/4.5 Measured by Impulse Oscillometry (IOS)
Last Updated: March 23, 2009
Condition(s): Asthma
20
Completed
Effects on Small Airways of Two Long-term Extrafine Treatments in Asthma
Last Updated: December 6, 2010
Condition(s): Bronchial Asthma

Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.

The URL of this page is: http://clinicaltrialsfeeds.org/clinical-trials/results/?term=Drug+Salmeterol+MDI

Page 1 of Clinical Trials for Drug Salmeterol MDI, 22 Total Matches

Get the Latest Results via Email or RSS

Subscribe via Web Newsreaders

Browse

Clinical Trials Background

About